Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

The International Journal of Neuropsychopharmacology
Felicity NgAshley I Bush

Abstract

Oxidative stress has been implicated in the pathogenesis of diverse disease states, and may be a common pathogenic mechanism underlying many major psychiatric disorders, as the brain has comparatively greater vulnerability to oxidative damage. This review aims to examine the current evidence for the role of oxidative stress in psychiatric disorders, and its academic and clinical implications. A literature search was conducted using the Medline, Pubmed, PsycINFO, CINAHL PLUS, BIOSIS Preview, and Cochrane databases, with a time-frame extending to September 2007. The broadest data for oxidative stress mechanisms have been derived from studies conducted in schizophrenia, where evidence is available from different areas of oxidative research, including oxidative marker assays, psychopharmacology studies, and clinical trials of antioxidants. For bipolar disorder and depression, a solid foundation for oxidative stress hypotheses has been provided by biochemical, genetic, pharmacological, preclinical therapeutic studies and one clinical trial. Oxidative pathophysiology in anxiety disorders is strongly supported by animal models, and also by human biochemical data. Pilot studies have suggested efficacy of N-acetylcysteine in cocaine dep...Continue Reading

References

Nov 1, 1987·Biological Psychiatry·T D BuckmanA Steinberg
Aug 1, 1994·Pharmacology, Biochemistry, and Behavior·S N Pal, P C Dandiya
Jan 1, 1995·Biochemical Society Symposium·K J Davies
Dec 6, 1996·International Journal of Cardiology·S KrishnaswamiS T Chandy
Mar 1, 1997·Experimental Physiology·H Sies
May 16, 1998·Biological Psychiatry·S P MahadikJ S Mahadik
Jun 17, 1998·Biological Psychiatry·L A AdlerJ Rotrosen
Aug 5, 1998·Schizophrenia Research·J K YaoD P van Kammen
Sep 4, 1998·Psychiatry Research·J K YaoD P van Kammen
May 26, 1999·American Journal of Respiratory Cell and Molecular Biology·T A SarafianM D Roth
Oct 13, 2000·The European Journal of Neuroscience·K Q DoM Cuénod
Nov 23, 2000·Nature·T Finkel, N J Holbrook
Feb 13, 2001·Psychiatry Research·J K YaoD P van Kammen
Feb 24, 2001·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·S PetruzzelliC Giuntini
Sep 5, 2001·The American Journal of Psychiatry·D C Goff, J T Coyle
Apr 30, 2002·Cell Biochemistry and Function·Murat KulogluNadire Cinkilinc
Jul 20, 2002·Journal of Psychiatric Research·S Salih ZorogluOmer Akyol
Oct 9, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Omer AkyolHaluk Asuman Savaş
Nov 26, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·O YorbikT Sohmen
Feb 5, 2003·Neuropsychobiology·Murat KulogluSerpil Bulut
Mar 18, 2003·Journal of Clinical Psychopharmacology·Xiang Yang ZhangYu Cun Shen
Apr 15, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sadik SöğütOmer Akyol
Apr 23, 2003·Neuropsychobiology·Medaim YanikOmer Akyol

❮ Previous
Next ❯

Citations

Nov 20, 2012·Social Psychiatry and Psychiatric Epidemiology·Felice N JackaStephen A Stansfeld
Aug 6, 2010·Journal of Neural Transmission·Bárbara TagliariAngela T S Wyse
Dec 7, 2011·Journal of Neural Transmission·Kelly Juliana SeibtCarla Denise Bonan
Apr 15, 2010·Neurotoxicity Research·Robert M Post
Nov 3, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ran BarzilayDaniel Offen
Aug 25, 2011·Molecular & Cellular Proteomics : MCP·Yaoyang ZhangChristoph W Turck
Mar 25, 2009·Antioxidants & Redox Signaling·Silvia Sorce, Karl-Heinz Krause
Apr 21, 2011·Schizophrenia Bulletin·Dilip V JesteBarton W Palmer
Mar 25, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S Jill JamesDavid W Gaylor
Jul 17, 2010·Behavioural Pharmacology·Kathryn J Reissner, Peter W Kalivas
Apr 27, 2010·TheScientificWorldJournal·Rodrigo Machado-VieiraCarlos A Zarate
Jul 27, 2010·Psychiatry and Clinical Neurosciences·Masateru MatsushitaYoshiro Sugita
Oct 14, 2009·Clinical Microbiology Reviews·Roland W Freudenmann, Peter Lepping
Feb 16, 2011·BMC Psychiatry·Juan Antonio MicóAna González-Pinto
Nov 20, 2012·BMC Psychiatry·Ana Gonzalez-PintoJuan Antonio Micó
Apr 4, 2013·Journal of Neuroinflammation·Souhel NajjarOrrin Devinsky
Apr 20, 2012·Environmental Health Perspectives·Youn-Hee LimYun-Chul Hong
Oct 1, 2011·PloS One·Felice N JackaBoyd A Swinburn
Dec 25, 2013·PloS One·Chih-Jen HungChun-Jung Chen
Dec 2, 2010·Journal of Psychiatry & Neuroscience : JPN·Olivia DeanMichael Berk
Feb 22, 2011·Pharmacogenomics·Fayçal MouaffakMarie Odile Krebs
Dec 25, 2010·Indian Journal of Psychiatry·Mohammed S MustakT S Sathyanarayana Rao
Feb 21, 2014·Pharmacological Reports : PR·Marcin SiwekGabriel Nowak
Jan 15, 2014·Journal of Ethnopharmacology·Muhammad Shahdaat Bin SayeedMd Asaduzzaman
Mar 29, 2014·International Journal of Endocrinology·Hamidreza RoohafzaNizal Sarrafzadegan
Dec 19, 2013·Oxidative Medicine and Cellular Longevity·Maria LucaCarmela Calandra
Jun 6, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Yinan ZhangWei Jia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.